APO Research, Inc.

Global Cell Freezing Media Market Outlook and Growth Opportunities 2026

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchIndustry Growth & TrendsMarket StructureMarket Outlook & Growth OpportunitiesSelectedMarket Analysis & Forecast
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceView editionView editionView editionCurrent editionView edition
View pricing & licenses

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Product & engineering

Understand the product.

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Selected research

Market Outlook & Growth Opportunities

Global Cell Freezing Media Market Outlook and Growth Opportunities 2026

MARKET AT A GLANCE

Scale & outlook

2025
279.46USD million
2032
568.98USD million
Market size · USD million
03006002025 · 279.46 USD million279.4620252026 · 310.86 USD million310.8620262032 · 568.98 USD million568.982032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global Cell Freezing Media market was valued at USD 279.46 million in 2025, is estimated to reach USD 310.86 million in 2026, and is projected to increase to USD 568.98 million by 2032, representing a compound annual growth rate (CAGR) of 10.60% from 2026 to 2032. Market expansion is primarily associated with increasing commercial cell therapy production, greater utilization of formulated cryopreservation media in biopharmaceutical cell banking, and the adoption of specialized formulations for clinically manufactured cellular products. Cell therapy manufacturing generates recurring demand through cell collection, expansion, intermediate freezing, and final product filling, with consumption determined by processed cell volumes, manufacturing batch frequency, and the amount of freezing medium required per cell preparation. Biopharmaceutical manufacturing uses these products for master and working cell banks, where demand is associated with new production cell lines, manufacturing process development, and periodic bank replenishment. Research laboratories and biorepositories contribute additional consumption as new cell lines and biological specimens enter storage, although established frozen inventories require limited additional freezing medium.

The commercialization of cell therapies has established a significant source of demand for qualified cryopreservation formulations, particularly in the United States. BioLife Solutions reported revenue of USD 96.2 million in 2025, with its CryoStor product family accounting for 82% of the total. The company's biopreservation media revenue increased by USD 19.3 million, or 30%, during 2025, primarily reflecting higher demand from customers with commercially approved therapies. As of June 30, 2026, BioLife reported that its biopreservation media were incorporated into 18 commercial cell and gene therapies and approximately 250 ongoing commercially sponsored clinical trials in the United States. Repligen completed its acquisition of BioLife in October 2026, consolidating an established clinical cryopreservation media business with its bioprocessing operations. Clinical adoption establishes formulation specific requirements for cell viability, recovery, residual cryoprotectant exposure, and manufacturing consistency. Once incorporated into a validated therapeutic manufacturing process, changes to freezing media can require additional compatibility studies and process qualification, influencing supplier continuity and the commercial value of established formulations.

DMSO containing media remain widely used for routine cell banking and the preservation of established mammalian cell lines, stem cells, and immune cells. Sartorius supplies NutriFreez D10 and D5 formulations containing 10% and 5% DMSO, respectively, addressing different cell preservation and clinical processing requirements. FUJIFILM offers PRIME XV FreezIS formulations with and without DMSO, including products intended for further therapeutic manufacturing. In China, Yocon Biotechnology supplies GMP grade DMSO free freezing media for mesenchymal stem cells and other cellular preparations, while Japan's ZENOGEN PHARMA supplies both conventional and DMSO free CELLBANKER formulations. The development of chemically defined, serum free, and animal component free products reflects the requirements of clinical manufacturing processes for controlled raw material composition and reproducible post thaw cell performance. Revenue growth is expected to derive principally from higher commercial consumption and a changing mix of research and clinical formulations. Realized selling prices remain dependent on formulation complexity, aseptic manufacturing requirements, packaging configurations, customer qualification requirements, and procurement volumes. Competition from established international manufacturers and regional suppliers is expected to constrain price increases in conventional formulations, while specialized products retain differentiated pricing based on their manufacturing specifications and approved customer applications.

Full market overview

This report provides an overview of the global Cell Freezing Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Freezing Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Freezing Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cell Freezing Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell Freezing Media Segment by Company

  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Cell Freezing Media Segment by Type

  • DMSO Containing
  • DMSO Free

Cell Freezing Media Segment by Application

  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine

Cell Freezing Media Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Study Objectives

  1. To analyze and research the global Cell Freezing Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
  2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
  3. To split the breakdown data by regions, type, manufacturers, and Application.
  4. To analyze the global and key regions Cell Freezing Media market potential and advantage, opportunity and challenge, restraints, and risks.
  5. To identify Cell Freezing Media significant trends, drivers, influence factors in global and regions.
  6. To analyze Cell Freezing Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Freezing Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Cell Freezing Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market.
  5. This report helps stakeholders to gain insights into which regions to target globally.
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Freezing Media.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Provides an overview of the Cell Freezing Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
  2. Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Freezing Media industry.
  3. Chapter 3: Detailed analysis of Cell Freezing Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  4. Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  5. Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  6. Chapter 6: Sales and value of Cell Freezing Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  7. Chapter 7: Sales and value of Cell Freezing Media in country level. It provides sigmate data by Type, and by Application for each country/region.
  8. Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  9. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
  10. Chapter 10: Concluding Insights.

More report detail

Tables and figures

List of Tables

  • Table 1. Cell Freezing Media Industry Trends
  • Table 2. Cell Freezing Media Industry Drivers
  • Table 3. Cell Freezing Media Industry Opportunities and Challenges
  • Table 4. Cell Freezing Media Industry Restraints
  • Table 5. Global Cell Freezing Media Revenue by Company (US$ Million) & (2021-2026)
  • Table 6. Global Cell Freezing Media Revenue Share by Company (2021-2026)
  • Table 7. Global Cell Freezing Media Sales Volume by Company (L) & (2021-2026)
  • Table 8. Global Cell Freezing Media Sales Volume Share by Company (2021-2026)
  • Table 9. Global Cell Freezing Media Average Price (USD/L) of Company (2021-2026)
  • Table 10. Global Cell Freezing Media Company Ranking, (2024-2026) & (USD Million)
  • Table 11. Global Cell Freezing Media Key Company Manufacturing Base & Headquarters
  • Table 12. Global Cell Freezing Media Company, Product Type & Application
  • Table 13. Global Cell Freezing Media Company Establishment Date
  • Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
  • Table 15. Global Cell Freezing Media by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
  • Table 16. Mergers & Acquisitions, Expansion
  • Table 17. Significant Companies of DMSO Containing
  • Table 18. Significant Companies of DMSO Free
  • Table 19. Global Cell Freezing Media Sales Volume by Type 2021 VS 2025 VS 2032 (L)
  • Table 20. Global Cell Freezing Media Sales Volume by Type (2021-2026) & (L)
  • Table 21. Global Cell Freezing Media Sales Volume by Type (2027-2032) & (L)
  • Table 22. Global Cell Freezing Media Sales Volume Share by Type (2021-2026)
  • Table 23. Global Cell Freezing Media Sales Volume Share by Type (2027-2032)
  • Table 24. Global Cell Freezing Media Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
  • Table 25. Global Cell Freezing Media Sales Value by Type (2021-2026) & (US$ Million)
  • Table 26. Global Cell Freezing Media Sales Value by Type (2027-2032) & (US$ Million)
  • Table 27. Global Cell Freezing Media Sales Value Share by Type (2021-2026)
  • Table 28. Global Cell Freezing Media Sales Value Share by Type (2027-2032)
  • Table 29. Significant Companies of Research
  • Table 30. Significant Companies of Biobanking
  • Table 31. Significant Companies of Biopharmaceutical Manufacturing
  • Table 32. Significant Companies of Cell Therapy and Regenerative Medicine
  • Table 33. Global Cell Freezing Media Sales Volume by Application 2021 VS 2025 VS 2032 (L)
  • Table 34. Global Cell Freezing Media Sales Volume by Application (2021-2026) & (L)
  • Table 35. Global Cell Freezing Media Sales Volume by Application (2027-2032) & (L)
  • Table 36. Global Cell Freezing Media Sales Volume Share by Application (2021-2026)
  • Table 37. Global Cell Freezing Media Sales Volume Share by Application (2027-2032)
  • Table 38. Global Cell Freezing Media Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
  • Table 39. Global Cell Freezing Media Sales Value by Application (2021-2026) & (US$ Million)
  • Table 40. Global Cell Freezing Media Sales Value by Application (2027-2032) & (US$ Million)
  • Table 41. Global Cell Freezing Media Sales Value Share by Application (2021-2026)
  • Table 42. Global Cell Freezing Media Sales Value Share by Application (2027-2032)
  • Table 43. Global Cell Freezing Media Sales by Region: 2021 VS 2025 VS 2032 (L)
  • Table 44. Global Cell Freezing Media Sales by Region (2021-2026) & (L)
  • Table 45. Global Cell Freezing Media Sales Market Share by Region (2021-2026)
  • Table 46. Global Cell Freezing Media Sales by Region (2027-2032) & (L)
  • Table 47. Global Cell Freezing Media Sales Market Share by Region (2027-2032)
  • Table 48. Global Cell Freezing Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 49. Global Cell Freezing Media Sales Value by Region (2021-2026) & (US$ Million)
  • Table 50. Global Cell Freezing Media Sales Value Share by Region (2021-2026)
  • Table 51. Global Cell Freezing Media Sales Value by Region (2027-2032) & (US$ Million)
  • Table 52. Global Cell Freezing Media Sales Value Share by Region (2027-2032)
  • Table 53. Global Cell Freezing Media Market Average Price (USD/L) by Region (2021-2026)
  • Table 54. Global Cell Freezing Media Market Average Price (USD/L) by Region (2027-2032)
  • Table 55. Global Cell Freezing Media Sales by Country: 2021 VS 2025 VS 2032 (L)
  • Table 56. Global Cell Freezing Media Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 57. Global Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 58. Global Cell Freezing Media Sales Market Share by Country (2021-2026)
  • Table 59. Global Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 60. Global Cell Freezing Media Sales Market Share by Country (2027-2032)
  • Table 61. Global Cell Freezing Media Sales Value by Country (2021-2026) & (US$ Million)
  • Table 62. Global Cell Freezing Media Sales Value Market Share by Country (2021-2026)
  • Table 63. Global Cell Freezing Media Sales Value by Country (2027-2032) & (US$ Million)
  • Table 64. Global Cell Freezing Media Sales Value Market Share by Country (2027-2032)
  • Table 65. Thermo Fisher Scientific Company Information
  • Table 66. Thermo Fisher Scientific Business Overview
  • Table 67. Thermo Fisher Scientific Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 68. Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  • Table 69. Thermo Fisher Scientific Recent Development
  • Table 70. Merck Company Information
  • Table 71. Merck Business Overview
  • Table 72. Merck Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 73. Merck Cell Freezing Media Product Portfolio
  • Table 74. Merck Recent Development
  • Table 75. Cytiva Company Information
  • Table 76. Cytiva Business Overview
  • Table 77. Cytiva Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 78. Cytiva Cell Freezing Media Product Portfolio
  • Table 79. Cytiva Recent Development
  • Table 80. Sartorius Company Information
  • Table 81. Sartorius Business Overview
  • Table 82. Sartorius Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 83. Sartorius Cell Freezing Media Product Portfolio
  • Table 84. Sartorius Recent Development
  • Table 85. FUJIFILM Company Information
  • Table 86. FUJIFILM Business Overview
  • Table 87. FUJIFILM Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 88. FUJIFILM Cell Freezing Media Product Portfolio
  • Table 89. FUJIFILM Recent Development
  • Table 90. BioLife Solutions Company Information
  • Table 91. BioLife Solutions Business Overview
  • Table 92. BioLife Solutions Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 93. BioLife Solutions Cell Freezing Media Product Portfolio
  • Table 94. BioLife Solutions Recent Development
  • Table 95. Lonza Company Information
  • Table 96. Lonza Business Overview
  • Table 97. Lonza Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 98. Lonza Cell Freezing Media Product Portfolio
  • Table 99. Lonza Recent Development
  • Table 100. STEMCELL Technologies Company Information
  • Table 101. STEMCELL Technologies Business Overview
  • Table 102. STEMCELL Technologies Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 103. STEMCELL Technologies Cell Freezing Media Product Portfolio
  • Table 104. STEMCELL Technologies Recent Development
  • Table 105. Miltenyi Biotec Company Information
  • Table 106. Miltenyi Biotec Business Overview
  • Table 107. Miltenyi Biotec Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 108. Miltenyi Biotec Cell Freezing Media Product Portfolio
  • Table 109. Miltenyi Biotec Recent Development
  • Table 110. Bio Techne Company Information
  • Table 111. Bio Techne Business Overview
  • Table 112. Bio Techne Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 113. Bio Techne Cell Freezing Media Product Portfolio
  • Table 114. Bio Techne Recent Development
  • Table 115. Avantor Company Information
  • Table 116. Avantor Business Overview
  • Table 117. Avantor Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 118. Avantor Cell Freezing Media Product Portfolio
  • Table 119. Avantor Recent Development
  • Table 120. HiMedia Laboratories Company Information
  • Table 121. HiMedia Laboratories Business Overview
  • Table 122. HiMedia Laboratories Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 123. HiMedia Laboratories Cell Freezing Media Product Portfolio
  • Table 124. HiMedia Laboratories Recent Development
  • Table 125. ZENOAQ Company Information
  • Table 126. ZENOAQ Business Overview
  • Table 127. ZENOAQ Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 128. ZENOAQ Cell Freezing Media Product Portfolio
  • Table 129. ZENOAQ Recent Development
  • Table 130. PAN Biotech Company Information
  • Table 131. PAN Biotech Business Overview
  • Table 132. PAN Biotech Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 133. PAN Biotech Cell Freezing Media Product Portfolio
  • Table 134. PAN Biotech Recent Development
  • Table 135. PromoCell Company Information
  • Table 136. PromoCell Business Overview
  • Table 137. PromoCell Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 138. PromoCell Cell Freezing Media Product Portfolio
  • Table 139. PromoCell Recent Development
  • Table 140. MP Biomedicals Company Information
  • Table 141. MP Biomedicals Business Overview
  • Table 142. MP Biomedicals Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 143. MP Biomedicals Cell Freezing Media Product Portfolio
  • Table 144. MP Biomedicals Recent Development
  • Table 145. ATCC Company Information
  • Table 146. ATCC Business Overview
  • Table 147. ATCC Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 148. ATCC Cell Freezing Media Product Portfolio
  • Table 149. ATCC Recent Development
  • Table 150. Teknova Company Information
  • Table 151. Teknova Business Overview
  • Table 152. Teknova Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 153. Teknova Cell Freezing Media Product Portfolio
  • Table 154. Teknova Recent Development
  • Table 155. Yocon Biotechnology Company Information
  • Table 156. Yocon Biotechnology Business Overview
  • Table 157. Yocon Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 158. Yocon Biotechnology Cell Freezing Media Product Portfolio
  • Table 159. Yocon Biotechnology Recent Development
  • Table 160. ExCell Bio Company Information
  • Table 161. ExCell Bio Business Overview
  • Table 162. ExCell Bio Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 163. ExCell Bio Cell Freezing Media Product Portfolio
  • Table 164. ExCell Bio Recent Development
  • Table 165. Shanghai BasalMedia Company Information
  • Table 166. Shanghai BasalMedia Business Overview
  • Table 167. Shanghai BasalMedia Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 168. Shanghai BasalMedia Cell Freezing Media Product Portfolio
  • Table 169. Shanghai BasalMedia Recent Development
  • Table 170. Dakewe Company Information
  • Table 171. Dakewe Business Overview
  • Table 172. Dakewe Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 173. Dakewe Cell Freezing Media Product Portfolio
  • Table 174. Dakewe Recent Development
  • Table 175. Cyagen Biosciences Company Information
  • Table 176. Cyagen Biosciences Business Overview
  • Table 177. Cyagen Biosciences Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 178. Cyagen Biosciences Cell Freezing Media Product Portfolio
  • Table 179. Cyagen Biosciences Recent Development
  • Table 180. Yeasen Biotechnology Company Information
  • Table 181. Yeasen Biotechnology Business Overview
  • Table 182. Yeasen Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 183. Yeasen Biotechnology Cell Freezing Media Product Portfolio
  • Table 184. Yeasen Biotechnology Recent Development
  • Table 185. Solarbio Company Information
  • Table 186. Solarbio Business Overview
  • Table 187. Solarbio Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 188. Solarbio Cell Freezing Media Product Portfolio
  • Table 189. Solarbio Recent Development
  • Table 190. Beyotime Biotechnology Company Information
  • Table 191. Beyotime Biotechnology Business Overview
  • Table 192. Beyotime Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 193. Beyotime Biotechnology Cell Freezing Media Product Portfolio
  • Table 194. Beyotime Biotechnology Recent Development
  • Table 195. Quality Biological Company Information
  • Table 196. Quality Biological Business Overview
  • Table 197. Quality Biological Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 198. Quality Biological Cell Freezing Media Product Portfolio
  • Table 199. Quality Biological Recent Development
  • Table 200. WELGENE Company Information
  • Table 201. WELGENE Business Overview
  • Table 202. WELGENE Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 203. WELGENE Cell Freezing Media Product Portfolio
  • Table 204. WELGENE Recent Development
  • Table 205. GC Lymphotec Company Information
  • Table 206. GC Lymphotec Business Overview
  • Table 207. GC Lymphotec Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 208. GC Lymphotec Cell Freezing Media Product Portfolio
  • Table 209. GC Lymphotec Recent Development
  • Table 210. Capricorn Scientific Company Information
  • Table 211. Capricorn Scientific Business Overview
  • Table 212. Capricorn Scientific Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 213. Capricorn Scientific Cell Freezing Media Product Portfolio
  • Table 214. Capricorn Scientific Recent Development
  • Table 215. Meilun Biotechnology Company Information
  • Table 216. Meilun Biotechnology Business Overview
  • Table 217. Meilun Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 218. Meilun Biotechnology Cell Freezing Media Product Portfolio
  • Table 219. Meilun Biotechnology Recent Development
  • Table 220. Nacalai Tesque Company Information
  • Table 221. Nacalai Tesque Business Overview
  • Table 222. Nacalai Tesque Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 223. Nacalai Tesque Cell Freezing Media Product Portfolio
  • Table 224. Nacalai Tesque Recent Development
  • Table 225. Saraya Company Information
  • Table 226. Saraya Business Overview
  • Table 227. Saraya Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 228. Saraya Cell Freezing Media Product Portfolio
  • Table 229. Saraya Recent Development
  • Table 230. ScienCell Research Laboratories Company Information
  • Table 231. ScienCell Research Laboratories Business Overview
  • Table 232. ScienCell Research Laboratories Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 233. ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  • Table 234. ScienCell Research Laboratories Recent Development
  • Table 235. Cell Applications Company Information
  • Table 236. Cell Applications Business Overview
  • Table 237. Cell Applications Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 238. Cell Applications Cell Freezing Media Product Portfolio
  • Table 239. Cell Applications Recent Development
  • Table 240. Nanjing Sansheng Biotechnology Company Information
  • Table 241. Nanjing Sansheng Biotechnology Business Overview
  • Table 242. Nanjing Sansheng Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 243. Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  • Table 244. Nanjing Sansheng Biotechnology Recent Development
  • Table 245. Pricella Biotechnology Company Information
  • Table 246. Pricella Biotechnology Business Overview
  • Table 247. Pricella Biotechnology Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 248. Pricella Biotechnology Cell Freezing Media Product Portfolio
  • Table 249. Pricella Biotechnology Recent Development
  • Table 250. CELLnTEC Company Information
  • Table 251. CELLnTEC Business Overview
  • Table 252. CELLnTEC Cell Freezing Media Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 253. CELLnTEC Cell Freezing Media Product Portfolio
  • Table 254. CELLnTEC Recent Development
  • Table 255. Key Raw Materials
  • Table 256. Raw Materials Key Suppliers
  • Table 257. Cell Freezing Media Distributors List
  • Table 258. Cell Freezing Media Customers List
  • Table 259. Research Programs/Design for This Report
  • Table 260. Authors List of This Report
  • Table 261. Secondary Sources
  • Table 262. Primary Sources

List of Figures

  • Figure 1. Cell Freezing Media Product Image
  • Figure 2. Global Cell Freezing Media Sales Value (US$ Million), 2021 VS 2025 VS 2032
  • Figure 3. Global Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 4. Global Cell Freezing Media Sales (2021-2032) & (L)
  • Figure 5. Global Cell Freezing Media Sales Average Price (USD/L) & (2021-2032)
  • Figure 6. Global Cell Freezing Media Company Revenue Ranking in 2025 (US$ Million)
  • Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
  • Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 9. DMSO Containing Image
  • Figure 10. DMSO Free Image
  • Figure 11. Global Cell Freezing Media Sales Volume by Type (2021 VS 2025 VS 2032) & (L)
  • Figure 12. Global Cell Freezing Media Sales Volume Share 2021 VS 2025 VS 2032
  • Figure 13. Global Cell Freezing Media Sales Volume Share by Type (2021-2032)
  • Figure 14. Global Cell Freezing Media Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 15. Global Cell Freezing Media Sales Value Share 2021 VS 2025 VS 2032
  • Figure 16. Global Cell Freezing Media Sales Value Share by Type (2021-2032)
  • Figure 17. Research Image
  • Figure 18. Biobanking Image
  • Figure 19. Biopharmaceutical Manufacturing Image
  • Figure 20. Cell Therapy and Regenerative Medicine Image
  • Figure 21. Global Cell Freezing Media Sales Volume by Application (2021 VS 2025 VS 2032) & (L)
  • Figure 22. Global Cell Freezing Media Sales Volume Share 2021 VS 2025 VS 2032
  • Figure 23. Global Cell Freezing Media Sales Volume Share by Application (2021-2032)
  • Figure 24. Global Cell Freezing Media Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 25. Global Cell Freezing Media Sales Value Share 2021 VS 2025 VS 2032
  • Figure 26. Global Cell Freezing Media Sales Value Share by Application (2021-2032)
  • Figure 27. Global Cell Freezing Media Sales by Region: 2021 VS 2025 VS 2032 (L)
  • Figure 28. Global Cell Freezing Media Sales Market Share by Region: 2021 VS 2025 VS 2032
  • Figure 29. Global Cell Freezing Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Figure 30. Global Cell Freezing Media Sales Value Share by Region: 2021 VS 2025 VS 2032
  • Figure 31. North America Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 32. North America Cell Freezing Media Sales Value Share by Country (%), 2025 VS 2032
  • Figure 33. Europe Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 34. Europe Cell Freezing Media Sales Value Share by Country (%), 2025 VS 2032
  • Figure 35. Asia-Pacific Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 36. Asia-Pacific Cell Freezing Media Sales Value Share by Country (%), 2025 VS 2032
  • Figure 37. South America Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 38. South America Cell Freezing Media Sales Value Share by Country (%), 2025 VS 2032
  • Figure 39. Middle East & Africa Cell Freezing Media Sales Value (2021-2032) & (US$ Million)
  • Figure 40. Middle East & Africa Cell Freezing Media Sales Value Share by Country (%), 2025 VS 2032
  • Figure 41. USA Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 42. USA Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 43. USA Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 44. Canada Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 45. Canada Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 46. Canada Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 47. Mexico Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 48. Mexico Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 49. Mexico Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 50. Germany Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 51. Germany Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 52. Germany Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 53. France Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 54. France Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 55. France Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 56. U.K. Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 57. U.K. Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 58. U.K. Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 59. Italy Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 60. Italy Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 61. Italy Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 62. Spain Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 63. Spain Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 64. Spain Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 65. Russia Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 66. Russia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 67. Russia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 68. Netherlands Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 69. Netherlands Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 70. Netherlands Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 71. Nordic Countries Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 72. Nordic Countries Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 73. Nordic Countries Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 74. China Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 75. China Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 76. China Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 77. Japan Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 78. Japan Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 79. Japan Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 80. South Korea Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 81. South Korea Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 82. South Korea Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 83. India Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 84. India Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 85. India Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 86. Australia Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 87. Australia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 88. Australia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 89. Southeast Asia Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 90. Southeast Asia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 91. Southeast Asia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 92. Brazil Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 93. Brazil Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 94. Brazil Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 95. Argentina Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 96. Argentina Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 97. Argentina Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 98. Chile Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 99. Chile Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 100. Chile Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 101. Colombia Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 102. Colombia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 103. Colombia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 104. Peru Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 105. Peru Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 106. Peru Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 107. Saudi Arabia Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 108. Saudi Arabia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 109. Saudi Arabia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 110. Israel Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 111. Israel Arabia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 112. Israel Arabia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 113. UAE Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 114. UAE Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 115. UAE Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 116. Turkey Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 117. Turkey Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 118. Turkey Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 119. Iran Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 120. Iran Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 121. Iran Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 122. Egypt Cell Freezing Media Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 123. Egypt Cell Freezing Media Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 124. Egypt Cell Freezing Media Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 125. Cell Freezing Media Value Chain
  • Figure 126. Manufacturing Cost Structure
  • Figure 127. Cell Freezing Media Sales Mode & Process
  • Figure 128. Direct Comparison with Distribution Share
  • Figure 129. Distributors Profiles
  • Figure 130. Years Considered
  • Figure 131. Research Process
  • Figure 132. Key Executives Interviewed

Scope & coverage.

By Type
  • DMSO Containing
  • DMSO Free
By Application
  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cell Freezing Media Sales Value (2021-2032)
  4. 1.2.2 Global Cell Freezing Media Sales Volume (2021-2032)
  5. 1.2.3 Global Cell Freezing Media Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cell Freezing Media Market Dynamics
  1. 2.1 Cell Freezing Media Industry Trends
  2. 2.2 Cell Freezing Media Industry Drivers
  3. 2.3 Cell Freezing Media Industry Opportunities and Challenges
  4. 2.4 Cell Freezing Media Industry Restraints
3 Cell Freezing Media Market by Company
  1. 3.1 Global Cell Freezing Media Company Revenue Ranking in 2025
  2. 3.2 Global Cell Freezing Media Revenue by Company (2021-2026)
  3. 3.3 Global Cell Freezing Media Sales Volume by Company (2021-2026)
  4. 3.4 Global Cell Freezing Media Average Price by Company (2021-2026)
  5. 3.5 Global Cell Freezing Media Company Ranking (2024-2026)
  6. 3.6 Global Cell Freezing Media Company Manufacturing Base and Headquarters
  7. 3.7 Global Cell Freezing Media Company Product Type and Application
  8. 3.8 Global Cell Freezing Media Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cell Freezing Media Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cell Freezing Media Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cell Freezing Media Market by Type
  1. 4.1 Cell Freezing Media Type Introduction
  2. 4.1.1 DMSO Containing
  3. 4.1.2 DMSO Free
  4. 4.2 Global Cell Freezing Media Sales Volume by Type
  5. 4.2.1 Global Cell Freezing Media Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cell Freezing Media Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cell Freezing Media Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cell Freezing Media Sales Value by Type
  9. 4.3.1 Global Cell Freezing Media Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cell Freezing Media Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cell Freezing Media Sales Value Share by Type (2021-2032)
5 Cell Freezing Media Market by Application
  1. 5.1 Cell Freezing Media Application Introduction
  2. 5.1.1 Research
  3. 5.1.2 Biobanking
  4. 5.1.3 Biopharmaceutical Manufacturing
  5. 5.1.4 Cell Therapy and Regenerative Medicine
  6. 5.2 Global Cell Freezing Media Sales Volume by Application
  7. 5.2.1 Global Cell Freezing Media Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cell Freezing Media Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Cell Freezing Media Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Cell Freezing Media Sales Value by Application
  11. 5.3.1 Global Cell Freezing Media Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cell Freezing Media Sales Value by Application (2021-2032)
  13. 5.3.3 Global Cell Freezing Media Sales Value Share by Application (2021-2032)
6 Cell Freezing Media Regional Sales and Value Analysis
  1. 6.1 Global Cell Freezing Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Freezing Media Sales by Region (2021-2032)
  3. 6.2.1 Global Cell Freezing Media Sales by Region: 2021-2026
  4. 6.2.2 Global Cell Freezing Media Sales by Region (2027-2032)
  5. 6.3 Global Cell Freezing Media Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cell Freezing Media Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cell Freezing Media Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cell Freezing Media Sales Value by Region (2027-2032)
  9. 6.5 Global Cell Freezing Media Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cell Freezing Media Sales Value (2021-2032)
  12. 6.6.2 North America Cell Freezing Media Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cell Freezing Media Sales Value (2021-2032)
  15. 6.7.2 Europe Cell Freezing Media Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cell Freezing Media Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cell Freezing Media Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cell Freezing Media Sales Value (2021-2032)
  21. 6.9.2 South America Cell Freezing Media Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cell Freezing Media Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cell Freezing Media Sales Value Share by Country, 2025 VS 2032
7 Cell Freezing Media Country-level Sales and Value Analysis
  1. 7.1 Global Cell Freezing Media Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell Freezing Media Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cell Freezing Media Sales by Country (2021-2032)
  4. 7.3.1 Global Cell Freezing Media Sales by Country (2021-2026)
  5. 7.3.2 Global Cell Freezing Media Sales by Country (2027-2032)
  6. 7.4 Global Cell Freezing Media Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cell Freezing Media Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cell Freezing Media Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cell Freezing Media Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cell Freezing Media Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.7.1 Mexico Cell Freezing Media Sales Value Growth Rate (2021-2032)
  19. 7.7.2 Mexico Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  20. 7.7.3 Mexico Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cell Freezing Media Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cell Freezing Media Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cell Freezing Media Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cell Freezing Media Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cell Freezing Media Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cell Freezing Media Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cell Freezing Media Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cell Freezing Media Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cell Freezing Media Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cell Freezing Media Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cell Freezing Media Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cell Freezing Media Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cell Freezing Media Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cell Freezing Media Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cell Freezing Media Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cell Freezing Media Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cell Freezing Media Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cell Freezing Media Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cell Freezing Media Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cell Freezing Media Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cell Freezing Media Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cell Freezing Media Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cell Freezing Media Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cell Freezing Media Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cell Freezing Media Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cell Freezing Media Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cell Freezing Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Cell Freezing Media Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Cytiva
  14. 8.3.1 Cytiva Company Information
  15. 8.3.2 Cytiva Business Overview
  16. 8.3.3 Cytiva Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cytiva Cell Freezing Media Product Portfolio
  18. 8.3.5 Cytiva Recent Developments
  19. 8.4 Sartorius
  20. 8.4.1 Sartorius Company Information
  21. 8.4.2 Sartorius Business Overview
  22. 8.4.3 Sartorius Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sartorius Cell Freezing Media Product Portfolio
  24. 8.4.5 Sartorius Recent Developments
  25. 8.5 FUJIFILM
  26. 8.5.1 FUJIFILM Company Information
  27. 8.5.2 FUJIFILM Business Overview
  28. 8.5.3 FUJIFILM Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 FUJIFILM Cell Freezing Media Product Portfolio
  30. 8.5.5 FUJIFILM Recent Developments
  31. 8.6 BioLife Solutions
  32. 8.6.1 BioLife Solutions Company Information
  33. 8.6.2 BioLife Solutions Business Overview
  34. 8.6.3 BioLife Solutions Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BioLife Solutions Cell Freezing Media Product Portfolio
  36. 8.6.5 BioLife Solutions Recent Developments
  37. 8.7 Lonza
  38. 8.7.1 Lonza Company Information
  39. 8.7.2 Lonza Business Overview
  40. 8.7.3 Lonza Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lonza Cell Freezing Media Product Portfolio
  42. 8.7.5 Lonza Recent Developments
  43. 8.8 STEMCELL Technologies
  44. 8.8.1 STEMCELL Technologies Company Information
  45. 8.8.2 STEMCELL Technologies Business Overview
  46. 8.8.3 STEMCELL Technologies Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 STEMCELL Technologies Cell Freezing Media Product Portfolio
  48. 8.8.5 STEMCELL Technologies Recent Developments
  49. 8.9 Miltenyi Biotec
  50. 8.9.1 Miltenyi Biotec Company Information
  51. 8.9.2 Miltenyi Biotec Business Overview
  52. 8.9.3 Miltenyi Biotec Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Miltenyi Biotec Cell Freezing Media Product Portfolio
  54. 8.9.5 Miltenyi Biotec Recent Developments
  55. 8.10 Bio Techne
  56. 8.10.1 Bio Techne Company Information
  57. 8.10.2 Bio Techne Business Overview
  58. 8.10.3 Bio Techne Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bio Techne Cell Freezing Media Product Portfolio
  60. 8.10.5 Bio Techne Recent Developments
  61. 8.11 Avantor
  62. 8.11.1 Avantor Company Information
  63. 8.11.2 Avantor Business Overview
  64. 8.11.3 Avantor Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Avantor Cell Freezing Media Product Portfolio
  66. 8.11.5 Avantor Recent Developments
  67. 8.12 HiMedia Laboratories
  68. 8.12.1 HiMedia Laboratories Company Information
  69. 8.12.2 HiMedia Laboratories Business Overview
  70. 8.12.3 HiMedia Laboratories Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 HiMedia Laboratories Cell Freezing Media Product Portfolio
  72. 8.12.5 HiMedia Laboratories Recent Developments
  73. 8.13 ZENOAQ
  74. 8.13.1 ZENOAQ Company Information
  75. 8.13.2 ZENOAQ Business Overview
  76. 8.13.3 ZENOAQ Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ZENOAQ Cell Freezing Media Product Portfolio
  78. 8.13.5 ZENOAQ Recent Developments
  79. 8.14 PAN Biotech
  80. 8.14.1 PAN Biotech Company Information
  81. 8.14.2 PAN Biotech Business Overview
  82. 8.14.3 PAN Biotech Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 PAN Biotech Cell Freezing Media Product Portfolio
  84. 8.14.5 PAN Biotech Recent Developments
  85. 8.15 PromoCell
  86. 8.15.1 PromoCell Company Information
  87. 8.15.2 PromoCell Business Overview
  88. 8.15.3 PromoCell Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 PromoCell Cell Freezing Media Product Portfolio
  90. 8.15.5 PromoCell Recent Developments
  91. 8.16 MP Biomedicals
  92. 8.16.1 MP Biomedicals Company Information
  93. 8.16.2 MP Biomedicals Business Overview
  94. 8.16.3 MP Biomedicals Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 MP Biomedicals Cell Freezing Media Product Portfolio
  96. 8.16.5 MP Biomedicals Recent Developments
  97. 8.17 ATCC
  98. 8.17.1 ATCC Company Information
  99. 8.17.2 ATCC Business Overview
  100. 8.17.3 ATCC Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 ATCC Cell Freezing Media Product Portfolio
  102. 8.17.5 ATCC Recent Developments
  103. 8.18 Teknova
  104. 8.18.1 Teknova Company Information
  105. 8.18.2 Teknova Business Overview
  106. 8.18.3 Teknova Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Teknova Cell Freezing Media Product Portfolio
  108. 8.18.5 Teknova Recent Developments
  109. 8.19 Yocon Biotechnology
  110. 8.19.1 Yocon Biotechnology Company Information
  111. 8.19.2 Yocon Biotechnology Business Overview
  112. 8.19.3 Yocon Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Yocon Biotechnology Cell Freezing Media Product Portfolio
  114. 8.19.5 Yocon Biotechnology Recent Developments
  115. 8.20 ExCell Bio
  116. 8.20.1 ExCell Bio Company Information
  117. 8.20.2 ExCell Bio Business Overview
  118. 8.20.3 ExCell Bio Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 ExCell Bio Cell Freezing Media Product Portfolio
  120. 8.20.5 ExCell Bio Recent Developments
  121. 8.21 Shanghai BasalMedia
  122. 8.21.1 Shanghai BasalMedia Company Information
  123. 8.21.2 Shanghai BasalMedia Business Overview
  124. 8.21.3 Shanghai BasalMedia Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai BasalMedia Cell Freezing Media Product Portfolio
  126. 8.21.5 Shanghai BasalMedia Recent Developments
  127. 8.22 Dakewe
  128. 8.22.1 Dakewe Company Information
  129. 8.22.2 Dakewe Business Overview
  130. 8.22.3 Dakewe Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Dakewe Cell Freezing Media Product Portfolio
  132. 8.22.5 Dakewe Recent Developments
  133. 8.23 Cyagen Biosciences
  134. 8.23.1 Cyagen Biosciences Company Information
  135. 8.23.2 Cyagen Biosciences Business Overview
  136. 8.23.3 Cyagen Biosciences Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Cyagen Biosciences Cell Freezing Media Product Portfolio
  138. 8.23.5 Cyagen Biosciences Recent Developments
  139. 8.24 Yeasen Biotechnology
  140. 8.24.1 Yeasen Biotechnology Company Information
  141. 8.24.2 Yeasen Biotechnology Business Overview
  142. 8.24.3 Yeasen Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Yeasen Biotechnology Cell Freezing Media Product Portfolio
  144. 8.24.5 Yeasen Biotechnology Recent Developments
  145. 8.25 Solarbio
  146. 8.25.1 Solarbio Company Information
  147. 8.25.2 Solarbio Business Overview
  148. 8.25.3 Solarbio Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Solarbio Cell Freezing Media Product Portfolio
  150. 8.25.5 Solarbio Recent Developments
  151. 8.26 Beyotime Biotechnology
  152. 8.26.1 Beyotime Biotechnology Company Information
  153. 8.26.2 Beyotime Biotechnology Business Overview
  154. 8.26.3 Beyotime Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Beyotime Biotechnology Cell Freezing Media Product Portfolio
  156. 8.26.5 Beyotime Biotechnology Recent Developments
  157. 8.27 Quality Biological
  158. 8.27.1 Quality Biological Company Information
  159. 8.27.2 Quality Biological Business Overview
  160. 8.27.3 Quality Biological Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Quality Biological Cell Freezing Media Product Portfolio
  162. 8.27.5 Quality Biological Recent Developments
  163. 8.28 WELGENE
  164. 8.28.1 WELGENE Company Information
  165. 8.28.2 WELGENE Business Overview
  166. 8.28.3 WELGENE Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 WELGENE Cell Freezing Media Product Portfolio
  168. 8.28.5 WELGENE Recent Developments
  169. 8.29 GC Lymphotec
  170. 8.29.1 GC Lymphotec Company Information
  171. 8.29.2 GC Lymphotec Business Overview
  172. 8.29.3 GC Lymphotec Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 GC Lymphotec Cell Freezing Media Product Portfolio
  174. 8.29.5 GC Lymphotec Recent Developments
  175. 8.30 Capricorn Scientific
  176. 8.30.1 Capricorn Scientific Company Information
  177. 8.30.2 Capricorn Scientific Business Overview
  178. 8.30.3 Capricorn Scientific Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 Capricorn Scientific Cell Freezing Media Product Portfolio
  180. 8.30.5 Capricorn Scientific Recent Developments
  181. 8.31 Meilun Biotechnology
  182. 8.31.1 Meilun Biotechnology Company Information
  183. 8.31.2 Meilun Biotechnology Business Overview
  184. 8.31.3 Meilun Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  185. 8.31.4 Meilun Biotechnology Cell Freezing Media Product Portfolio
  186. 8.31.5 Meilun Biotechnology Recent Developments
  187. 8.32 Nacalai Tesque
  188. 8.32.1 Nacalai Tesque Company Information
  189. 8.32.2 Nacalai Tesque Business Overview
  190. 8.32.3 Nacalai Tesque Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  191. 8.32.4 Nacalai Tesque Cell Freezing Media Product Portfolio
  192. 8.32.5 Nacalai Tesque Recent Developments
  193. 8.33 Saraya
  194. 8.33.1 Saraya Company Information
  195. 8.33.2 Saraya Business Overview
  196. 8.33.3 Saraya Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  197. 8.33.4 Saraya Cell Freezing Media Product Portfolio
  198. 8.33.5 Saraya Recent Developments
  199. 8.34 ScienCell Research Laboratories
  200. 8.34.1 ScienCell Research Laboratories Company Information
  201. 8.34.2 ScienCell Research Laboratories Business Overview
  202. 8.34.3 ScienCell Research Laboratories Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  203. 8.34.4 ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  204. 8.34.5 ScienCell Research Laboratories Recent Developments
  205. 8.35 Cell Applications
  206. 8.35.1 Cell Applications Company Information
  207. 8.35.2 Cell Applications Business Overview
  208. 8.35.3 Cell Applications Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  209. 8.35.4 Cell Applications Cell Freezing Media Product Portfolio
  210. 8.35.5 Cell Applications Recent Developments
  211. 8.36 Nanjing Sansheng Biotechnology
  212. 8.36.1 Nanjing Sansheng Biotechnology Company Information
  213. 8.36.2 Nanjing Sansheng Biotechnology Business Overview
  214. 8.36.3 Nanjing Sansheng Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  215. 8.36.4 Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  216. 8.36.5 Nanjing Sansheng Biotechnology Recent Developments
  217. 8.37 Pricella Biotechnology
  218. 8.37.1 Pricella Biotechnology Company Information
  219. 8.37.2 Pricella Biotechnology Business Overview
  220. 8.37.3 Pricella Biotechnology Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  221. 8.37.4 Pricella Biotechnology Cell Freezing Media Product Portfolio
  222. 8.37.5 Pricella Biotechnology Recent Developments
  223. 8.38 CELLnTEC
  224. 8.38.1 CELLnTEC Company Information
  225. 8.38.2 CELLnTEC Business Overview
  226. 8.38.3 CELLnTEC Cell Freezing Media Sales, Value and Gross Margin (2021-2026)
  227. 8.38.4 CELLnTEC Cell Freezing Media Product Portfolio
  228. 8.38.5 CELLnTEC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cell Freezing Media Value Chain Analysis
  2. 9.1.1 Cell Freezing Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cell Freezing Media Sales Mode & Process
  6. 9.2 Cell Freezing Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cell Freezing Media Distributors
  9. 9.2.3 Cell Freezing Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.